We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+10.89%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$36.2B
AUM Growth
+$2.03B
(+6%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
14.34%
Holding
2,349
New
214
Increased
749
Reduced
1,086
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$165M |
| 2 |
American Electric Power
AEP
|
+$143M |
| 3 |
Duke Energy
DUK
|
+$123M |
| 4 |
Medtronic
MDT
|
+$121M |
| 5 |
Eli Lilly
LLY
|
+$86.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$211M |
| 2 |
Chevron
CVX
|
+$186M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$169M |
| 5 |
ExxonMobil
XOM
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.91% |
| 2 | Financials | 14.92% |
| 3 | Technology | 12.39% |
| 4 | Consumer Discretionary | 8.32% |
| 5 | Consumer Staples | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Constellation Brands
STZ
$21.1B
| $25.7M | 0.07% |
110,713
-8,536
| -7% | -$2.04M |
|
327
AbCellera Biologics
ABCL
$3.7B
| $25.6M | 0.07% |
2,522,322
+418,281
| +20% | +$4.83M |
|
328
Johnson Controls International
JCI
$83.8B
| $25.5M | 0.07% |
397,760
+78,953
| +25% | +$4.83M |
|
|
SYNH
329
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $25.4M | 0.07% |
692,989
+612,816
| +764% | +$24.2M |
|
330
Cognex
CGNX
$9.95B
| $25.3M | 0.07% |
537,217
-212,697
| -28% | -$9.97M |
|
331
Stryker
SYK
$108B
| $25.3M | 0.07% |
103,289
-9,615
| -9% | -$2.18M |
|
332
Power Integrations
POWI
$2.7B
| $25.2M | 0.07% |
351,483
+26,360
| +8% | +$1.88M |
|
333
Sportradar
SRAD
$3.94B
| $25.1M | 0.07% |
2,524,300
-265,500
| -10% | -$2.59M |
|
334
Brighthouse Financial
BHF
$2.82B
| $25.1M | 0.07% |
488,821
-7,972
| -2% | -$417K |
|
335
Cooper Companies
COO
$10.1B
| $24.9M | 0.07% |
301,632
-33,412
| -10% | -$2.46M |
|
336
John Wiley & Sons Class A
WLY
$2.5B
| $24.7M | 0.07% |
617,048
-140,123
| -19% | -$5.87M |
|
337
McDonald's
MCD
$179B
| $24.5M | 0.07% |
93,154
-42,094
| -31% | -$11.1M |
|
338
Zentalis Pharmaceuticals
ZNTL
$296M
| $24.4M | 0.07% |
1,211,600
+125,000
| +12% | +$2.69M |
|
339
MetLife
MET
$62.4B
| $24.3M | 0.07% |
336,022
-6,898
| -2% | -$494K |
|
340
Quanta Services
PWR
$92.2B
| $24.2M | 0.07% |
169,920
+168,744
| +14,349% | +$24M |
|
341
Moelis & Co
MC
$4.51B
| $24M | 0.07% |
625,000
-457,735
| -42% | -$18.6M |
|
|
AQUA
342
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $23.9M | 0.07% |
602,700
-97
| -0% | -$3.81K |
|
|
CFB
343
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $23.5M | 0.06% |
1,890,341
-12
| -0% | -$160 |
|
344
United Rentals
URI
$61.6B
| $23.4M | 0.06% |
65,930
+10,580
| +19% | +$3.48M |
|
345
LPL Financial
LPLA
$26.9B
| $23.4M | 0.06% |
108,068
-15,528
| -13% | -$3.63M |
|
346
Penumbra
PEN
$12.5B
| $23.3M | 0.06% |
104,916
-1,367
| -1% | -$267K |
|
|
KDNY
347
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $23.3M | 0.06% |
888,454
+750,191
| +543% | +$16.6M |
|
|
DCT
348
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $23.1M | 0.06% |
1,919,526
+72,209
| +4% | +$828K |
|
349
Federated Hermes Short Duration Corporate ETF
FCSH
$66.6M
| $22.9M | 0.06% |
990,004
| – | – |
|
350
Moderna
MRNA
$57.4B
| $22.9M | 0.06% |
127,415
-42,798
| -25% | -$7M |
|
Similar funds
Federated Hermes's Q4 2022 Portfolio in Review
As of Q4 2022, Federated Hermes held 2,349 positions worth $36.2B, up 6% from $34.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Federated Hermes's Q4 2022 filing shows 214 new, 749 increased, 1,086 reduced and 196 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M. The largest sale was Amgen, an estimated $211M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q4 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 310,000 shares worth $26.2M.
- Federated Hermes added most to LyondellBasell Industries in Q4 2022, an estimated $165M increase.
- Federated Hermes's biggest Q4 2022 reduction was Amgen, cutting an estimated $211M.
- Federated Hermes fully exited Akouos Inc in Q4 2022, selling an estimated $27M.
- Federated Hermes's ten largest holdings make up 14% of its $36.2B portfolio in Q4 2022.
- Federated Hermes opened 214 new positions and closed 196 in Q4 2022.
- Federated Hermes's portfolio value rose 6% quarter-over-quarter to $36.2B.
Based on Federated Hermes's 13F filing for Q4 2022, filed 13 Feb 2023.